AstraZeneca (AZN) Acquires Biologics Manufacturing Facility from Amgen (AMGN)
AstraZeneca (NYSE: AZN) added to its biologics manufacturing capability in the US with the purchase of a high-tech biologics bulk ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)